Skip to Content

Oak Street Health, Inc.

Merger

  • Date:
  • 2/8/2023
  • Company Name:
  • Oak Street Health, Inc.
  • Stock Symbol:
  • OSH
  • Company Name - Buyer:
  • CVS Health®
  • Stock Symbol - Buyer:
  • CVS
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 2/8/2023

Case Finder

Locate any case using the tools below.

NEW YORK, February 8, 2023 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Oak Street Health, Inc. (NYSE: OSH) (“Oak Street”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by CVS Health® (NYSE: CVS) (“CVS”).

On February 8, 2023, Oak Street announced that it had entered into an agreement to be acquired by CVS in a $10.6 billion all-cash deal. Pursuant to the merger agreement, CVS Health will acquire Oak Street Health at $39 per share. The deal is expected to close in 2023.

Bragar Eagel & Squire is concerned that Oak Street’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Oak Street’s stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Oak Street Health. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: